<?xml version="1.0" encoding="UTF-8"?>
<ref id="B98-viruses-12-00339">
 <label>98.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yao</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Pike</surname>
    <given-names>S.E.</given-names>
   </name>
   <name>
    <surname>Pittaluga</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Cherney</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Gupta</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Jaffe</surname>
    <given-names>E.S.</given-names>
   </name>
   <name>
    <surname>Tosato</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin</article-title>
  <source>Cancer Immunol. Immunother.</source>
  <year>2002</year>
  <volume>51</volume>
  <fpage>358</fpage>
  <lpage>366</lpage>
  <pub-id pub-id-type="doi">10.1007/s00262-002-0294-2</pub-id>
  <pub-id pub-id-type="pmid">12192535</pub-id>
 </element-citation>
</ref>
